A semi-mechanistic model of the relationship between average glucose and HbA1c in healthy and diabetic subjects Rocío Lledó-GarcíaNorman A. MazerMats O. Karlsson Original Paper 10 January 2013 Pages: 129 - 142
Application of a mechanism-based disease systems model for osteoporosis to clinical data Teun M. PostStephan SchmidtMeindert Danhof Original Paper 12 January 2013 Pages: 143 - 156
Physiologically based pharmacokinetic model of lapatinib developed in mice and scaled to humans Susan F. HudachekDaniel L. Gustafson Original Paper 12 January 2013 Pages: 157 - 176
Estimation of parameters for the elimination of an orally administered test substance with unknown absorption Josef A. VogtChristian Denzer Original Paper 02 February 2013 Pages: 177 - 187
Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian Tatiana TatarinovaMichael NeelyAlan Schumitzky Original Paper 13 February 2013 Pages: 189 - 199
D optimal designs for three Poisson dose–response models Alan MaloneyUlrika S. H. SimonssonMarloes Schaddelee Original Paper 19 February 2013 Pages: 201 - 211
A PCA approach to population analysis: with application to a Phase II depression trial Eleonora MarosticaAlberto RussuGiuseppe De Nicolao Original Paper 17 March 2013 Pages: 213 - 227
Coupled solutions of one- and two-compartment pharmacokinetic models with first-order absorption N. AsmanovaG. KoloskovA. I. Ilin Original Paper 10 April 2013 Pages: 229 - 241
Cross-validation for nonlinear mixed effects models Emily ColbyEric Bair Original Paper 27 March 2013 Pages: 243 - 252
Erratum to: A physiologically-based recirculatory meta-model for nasal fentanyl in man Richard N. UptonDavid J. R. FosterLars Popper Erratum 30 January 2013 Pages: 253 - 253
